Novo Nordisk A/S (NVO)
49.05
+2.69
(+5.80%)
USD |
NYSE |
Dec 10, 16:00
49.67
+0.62
(+1.26%)
Pre-Market: 07:12
Novo Nordisk Profit Margin (Quarterly): 26.68% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Evaxion AS | -2.98K% |
| Ascendis Pharma A/S | -28.55% |
| Regeneron Pharmaceuticals, Inc. | 38.89% |
| Omeros Corp. | -- |
| Viking Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 68.76% |
| Return on Assets | 21.76% |
| Return on Invested Capital | 41.84% |
| Gross Profit Margin (Quarterly) | 76.12% |
| Operating Margin (Quarterly) | 31.74% |
| Return on Net Operating Assets | 27.04% |